These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1730624)

  • 1. Mutagenesis of the Arg-Gly-Asp triplet in human complement component C3 does not abolish binding of iC3b to the leukocyte integrin complement receptor type III (CR3, CD11b/CD18).
    Taniguchi-Sidle A; Isenman DE
    J Biol Chem; 1992 Jan; 267(1):635-43. PubMed ID: 1730624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand specificity of purified complement receptor type three (CD11b/CD18, alpha m beta 2, Mac-1). Indirect effects of an Arg-Gly-Asp (RGD) sequence.
    Van Strijp JA; Russell DG; Tuomanen E; Brown EJ; Wright SD
    J Immunol; 1993 Sep; 151(6):3324-36. PubMed ID: 8376780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C3bi receptor (complement receptor type 3) recognizes a region of complement protein C3 containing the sequence Arg-Gly-Asp.
    Wright SD; Reddy PA; Jong MT; Erickson BW
    Proc Natl Acad Sci U S A; 1987 Apr; 84(7):1965-8. PubMed ID: 3550803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the complement iC3b binding site in the beta 2 integrin CR3 (CD11b/CD18).
    Ueda T; Rieu P; Brayer J; Arnaout MA
    Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10680-4. PubMed ID: 7524101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).
    Yan J; Vetvicka V; Xia Y; Coxon A; Carroll MC; Mayadas TN; Ross GD
    J Immunol; 1999 Sep; 163(6):3045-52. PubMed ID: 10477568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
    Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
    J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leukocyte elastase is an endogenous ligand for the integrin CR3 (CD11b/CD18, Mac-1, alpha M beta 2) and modulates polymorphonuclear leukocyte adhesion.
    Cai TQ; Wright SD
    J Exp Med; 1996 Oct; 184(4):1213-23. PubMed ID: 8879192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin as functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b.
    Ross GD; Cain JA; Lachmann PJ
    J Immunol; 1985 May; 134(5):3307-15. PubMed ID: 2984286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in complement-mediated phagocytosis and podosome formation by human phagocytes.
    Lukácsi S; Nagy-Baló Z; Erdei A; Sándor N; Bajtay Z
    Immunol Lett; 2017 Sep; 189():64-72. PubMed ID: 28554712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage cytoskeleton association with CR3 and CR4 regulates receptor mobility and phagocytosis of iC3b-opsonized erythrocytes.
    Ross GD; Reed W; Dalzell JG; Becker SE; Hogg N
    J Leukoc Biol; 1992 Feb; 51(2):109-17. PubMed ID: 1358992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of residues in the C3dg region of human complement component C3 corresponding to a proposed binding site for complement receptor type 2 (CR2, CD21) does not abolish binding of iC3b or C3dg to CR2.
    Diefenbach RJ; Isenman DE
    J Immunol; 1995 Mar; 154(5):2303-20. PubMed ID: 7868901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of human complement component C3 with factor B and with complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) involve an acidic sequence at the N-terminus of C3 alpha'-chain.
    Taniguchi-Sidle A; Isenman DE
    J Immunol; 1994 Dec; 153(11):5285-302. PubMed ID: 7963581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the binding of C3S and C3F to complement receptors types 1, 2, and 3.
    Bartók I; Walport MJ
    J Immunol; 1995 May; 154(10):5367-75. PubMed ID: 7730637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phagocytosis via complement receptor 3 enables microbes to evade killing by neutrophils.
    Smirnov A; Daily KP; Gray MC; Ragland SA; Werner LM; Brittany Johnson M; Eby JC; Hewlett EL; Taylor RP; Criss AK
    J Leukoc Biol; 2023 Jul; 114(1):1-20. PubMed ID: 36882066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CR3 (CD11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide.
    Wright SD; Levin SM; Jong MT; Chad Z; Kabbash LG
    J Exp Med; 1989 Jan; 169(1):175-83. PubMed ID: 2462607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staurosporine inhibits neutrophil phagocytosis but not iC3b binding mediated by CR3 (CD11b/CD18).
    Roubey RA; Ross GD; Merrill JT; Walton F; Reed W; Winchester RJ; Buyon JP
    J Immunol; 1991 May; 146(10):3557-62. PubMed ID: 1673986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of recombinant fragments of CD11b expressing the functional beta-glucan-binding lectin site of CR3 (CD11b/CD18).
    Xia Y; Ross GD
    J Immunol; 1999 Jun; 162(12):7285-93. PubMed ID: 10358177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The leukocyte cell surface receptor(s) for the iC3b product of complement.
    Rosen H; Law SK
    Curr Top Microbiol Immunol; 1990; 153():99-122. PubMed ID: 2137074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells.
    Xia Y; Vetvicka V; Yan J; Hanikýrová M; Mayadas T; Ross GD
    J Immunol; 1999 Feb; 162(4):2281-90. PubMed ID: 9973505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand binding by the p150,95 antigen of U937 monocytic cells: properties in common with complement receptor type 3 (CR3).
    Malhotra V; Hogg N; Sim RB
    Eur J Immunol; 1986 Sep; 16(9):1117-23. PubMed ID: 3530784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.